Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (29588)	1/9/2008 3:55:36 PM
From: Jurgis Bekepuris	Respond to of 78464

I am starting to consider selling my AZN and GSK holdings as they are going up-ish while other things crash. IMHO, pharmas are in a very tight spot now. Last 4 years drug discovery rate was horrible and approval rate was similarly bad. Research expenditures per drug approved are skyrocketing while the approved drugs have much smaller markets than former blockbusters. IMHO, pharma situation will continue to get worse. OTOH, I will continue to hold JNJ, since it is Buffett holding and it is much more diversified company.